Brian Olson PhD

Assistant professor @WinshipatEmory, focused on tumor immunology and translating new discoveries in the lab into clinical trials. Tweets=my own. #immunonc

[SITC Early Career Scientist Committee @sitcancerECS]

Early career investigators! Apply now for a one-year, $100,000 @sitcancer - @AstraZenecaUS Immunotherapy in Lung Cancer Clinical Fellowship! Applications due March 27. #SITCFellowship #ECR https://t.co/1wAcZDphsz

[Brian Olson PhD @BrianOlsonPhD]

Hey all you early career scientists out there. Looking for great funding opportunities to help launch your research? Check out the Society for Immunotherapy of Cancer @sitcancer fellowship programs, open for applications now through March 27th.

https://t.co/BBjdyJLr4c

[Taofeek K Owonikoko @teekayowo]

Participating in the New York lung cancer foundation summit. Insightful and provocative presentations on big ideas to move the field forward ⁦@fred_hirsch⁩ ⁦@peters_solange⁩ ⁦@TonyMok9⁩ ⁦@UPMCHillmanCC⁩ ⁦@UPMCnews⁩ ⁦@IASLC⁩ ⁦@HwakeleeMD⁩

[Russell Pachynski @RPachynski]

Important to understand limitations of mouse studies (where we can perfectly regulate lipid/protein/glucose in chow) and the subtle differences on the immune system between metabolic states, and how this is relevant to humans. @BReinfeld @PatrickHwuMD

[Brian Olson PhD @BrianOlsonPhD]

Looks like a great group of undergrad scientists, Josh! Miss our Friday lab mtgs in the McNeel lab back in the day.

Any @UWMadison undergrad looking for a great mentor doing some cutting edge research needs to check out @JoshLangMD and his team!

[Josh Lang @JoshLangMD]

Kicking off the Spring Term with our monthly undergrad research meeting. What a crew! @UWCarbone @PCF_Science @uw_IMresidency https://t.co/DQpEdCWgJ2

[Brian Olson PhD @BrianOlsonPhD]

Interesting paper on CHIP alterations and CV disease. Nice work from Bonnie Ky and the team @PennMedicine

[Damian Clarke-Bruce @DCB_BioPharma]

DNMT3A and TET2 may serve as biomarkers of anthracycline-induced cardiotoxicity. Met Bonnie Ky, what an amazing person to chat with. #ACC23 @ICOSociety @SverdlovAaron @RaceOncology @JACCJournals @ACCinTouch

[EllisLab_ @EllisLab_]

😂😂😂 #truth always when time is essential

[Chrystal Paulos @Chrystal_Paulos]

💥 Exceptional talk by Dr. ⁦@HaydnKissick⁩ on harnessing CD8 T responses ⁦w/⁦@careyjans⁩, how they work in dLN & tumor w/ @nataliya_pro_⁩, & now bolstering CD4 Th1 help w/⁦@Maria⁦@Maria_Carden1⁩⁩! Shout out to ⁦@zach_buchwald⁩ and others too. 💥

[Brian Olson PhD @BrianOlsonPhD]

Very cool paper from @AkashPatnaik7 @KiranjChaudagar and the exceptional team @UCCancerCenter ! Prevalence of PTEN loss across malignancies highlights potential broad ranging applications for this treatment strategies! Beautiful work, @AkashPatnaik7 !

[Akash Patnaik, MD, PhD, MMSc @AkashPatnaik7]

Our story on immunometabolic strategies to treat PTEN-deficient aggressive-variant prostate cancers is finally out! Thanks to @PCF_Science and @UCCancerCenter for supporting this work.

[Brian Olson PhD @BrianOlsonPhD]

This is fantastic - way to continue the fight against cancer @ACS_Research and @Immunology4Life ! Curtis Henry @WinshipAtEmory is an awesome immunologist, and I’m honored to call him a colleague!
Keep on rocking on, Curtis!!!

[Lynne Elmore @lwelmore0320]

Honored to share the floor this evening w/ ⁦@ACSCAN⁩ board chair ⁦@maureenmann0224⁩ & ⁦@ACS_Research�� awardee Dr. Curtis Henry ⁦@WinshipAtEmory⁩. Enthusiasm & commitment all around to end cancer as we know it for everyone.

[Emory Cancer Biology Program @CancerBioEmory]

Congrats to Emory CB student, Kelsey Bennion, on her F99 perfect score! Always a 10 for us!

[Jay Bradner, M.D. @jaybradner]

You have to admit it kinda stinks that spatial transcriptomics (which i *love*) is hitting prime time 7-10 years after scRNA-seq. Now we all have to do the whole darn thing over again...

[TRCCC @TRCCC1998]

Congratulations poster award winner! #TRCCC2023

[Gregory Lesinski @LesinskiLab]

@natalie_horvat represents the Lesinski Lab @WinshipAtEmory @TRCCC1998 on novel immune data from a clinical trial of Hsp90/PD1 inhibition in #GIcancer

[Chrystal Paulos @Chrystal_Paulos]

Congrats to MSTP student Guillermo Rangel Rivera @GuillermoORang1 for 1st place on his cell therapy talk plus a travel award to @ImmunologyAAI ! @WinshipAtEmory @muschollings @PaulosLab @LesinskiLab

[Gregory Lesinski @LesinskiLab]

@phillipsmaggiej attacking #PancreaticCancer @WinshipAtEmory @TRCCC1998 with CD26 inhibitors and immune checkpoints!

[Gregory Lesinski @LesinskiLab]

Thanks again to @TRCCC1998 for the invitation to bring some southern charm from @WinshipAtEmory to this years 25th anniv meeting! @PaulosLab @natalie_horvat @phillipsmaggiej @AyanaTRuffin @GuillermoORang1 and soundarya kumaresan

[Vaccinex @Vaccinex]

Tomorrow @ 5:20 PM ET, @EmoryMedicine w/ Vaccinex will present "Neoadjuvant SEMA4D blockade w/ nivolumab alters suppressive myeloid cells while elevating B cell & CD26hi T cell infiltration in tumors of patients w/ resectable stage 3 melanoma" @ #SITC22. https://t.co/CAzCCMe7XY

[Brian Olson PhD @BrianOlsonPhD]

Way to represent the team, @sagarapatel @CardioOnc_ATL ! Excited to see this trial move forward to help reduce mortality for patients with prostate cancer. @PCFnews

[Winship Cancer Institute of Emory University @WinshipAtEmory]

Sagar Patel, MD, Brian Olson, PhD (not pictured) & Anant Mandawat, MD received a Challenge Award at @PCFNews Scientific Retreat for better understanding the mechanism of cardiovascular disease in patients with #prostatecancer receiving androgen deprivation therapy. #pcfretreat22

[Amanda (Ruggieri) Joyce, PhD 🐞 @amandanjoyce]

Two name changes in one week? Allow me to reintroduce myself: Amanda Ruggieri Joyce, PhD. Excited to begin this incredible next chapter of my life 👩🏻‍🎓💍